Matches in Wikidata for { <http://www.wikidata.org/entity/Q59216981> ?p ?o ?g. }
Showing items 1 to 52 of
52
with 100 items per page.
- Q59216981 description "article scientifique publié en 2008" @default.
- Q59216981 description "article" @default.
- Q59216981 description "wetenschappelijk artikel" @default.
- Q59216981 description "наукова стаття, опублікована у 2008" @default.
- Q59216981 name "96 weeks pharmacoeconomic outcome of lopinavir/r monotherapy as maintenance strategy in HIV+ patients with suppressed viral load. OK04-PharmECO analysis" @default.
- Q59216981 name "96 weeks pharmacoeconomic outcome of lopinavir/r monotherapy as maintenance strategy in HIV+ patients with suppressed viral load. OK04-PharmECO analysis" @default.
- Q59216981 type Item @default.
- Q59216981 label "96 weeks pharmacoeconomic outcome of lopinavir/r monotherapy as maintenance strategy in HIV+ patients with suppressed viral load. OK04-PharmECO analysis" @default.
- Q59216981 label "96 weeks pharmacoeconomic outcome of lopinavir/r monotherapy as maintenance strategy in HIV+ patients with suppressed viral load. OK04-PharmECO analysis" @default.
- Q59216981 prefLabel "96 weeks pharmacoeconomic outcome of lopinavir/r monotherapy as maintenance strategy in HIV+ patients with suppressed viral load. OK04-PharmECO analysis" @default.
- Q59216981 prefLabel "96 weeks pharmacoeconomic outcome of lopinavir/r monotherapy as maintenance strategy in HIV+ patients with suppressed viral load. OK04-PharmECO analysis" @default.
- Q59216981 P1433 Q59216981-2969BB14-814A-43C4-B9B6-DE5C530EC439 @default.
- Q59216981 P1476 Q59216981-8CFEB64F-641A-44D2-8587-52FF44B2181E @default.
- Q59216981 P2093 Q59216981-0C870B59-0ECA-476B-B537-EA33132AEDA5 @default.
- Q59216981 P2093 Q59216981-462F2167-E189-4198-B6C8-A8D9941A4688 @default.
- Q59216981 P2093 Q59216981-9616FFFE-34C1-46AE-A882-34DBC938812E @default.
- Q59216981 P2093 Q59216981-9E165ECE-2FFC-4ABC-88CA-4A14DC367543 @default.
- Q59216981 P2093 Q59216981-9EBD4C33-3085-4205-9689-BC1DCC55A811 @default.
- Q59216981 P2093 Q59216981-C5488779-A779-428C-AFF1-71B2690F3C15 @default.
- Q59216981 P2093 Q59216981-FEF16DE6-33EA-4BBB-B028-0F2892BBC20C @default.
- Q59216981 P2888 Q59216981-05ABAD25-DCF8-406A-A52D-D6D3594EE404 @default.
- Q59216981 P304 Q59216981-95C90F29-4F34-49F9-8638-8A3D2FB7A7DF @default.
- Q59216981 P31 Q59216981-E683581A-541E-42A2-85F9-5385888EDBBF @default.
- Q59216981 P356 Q59216981-03B0BA5B-B217-45BE-BD10-BB955A76A3BB @default.
- Q59216981 P433 Q59216981-0CAC8458-7F4F-44D7-9997-EECFF6EE7CCD @default.
- Q59216981 P478 Q59216981-91D61D62-E187-4B84-9EDC-7A22FF2A2F4E @default.
- Q59216981 P577 Q59216981-FE2BBE26-D51D-4B7E-B9E4-B4B742D83991 @default.
- Q59216981 P6179 Q59216981-5E50010D-42DC-46DE-A5B0-9055FCEDD359 @default.
- Q59216981 P921 Q59216981-201B6B12-5031-4656-8409-8A797AD19819 @default.
- Q59216981 P921 Q59216981-4DF9960A-8ACA-45E9-90B9-353726D872D8 @default.
- Q59216981 P921 Q59216981-BF70678B-40AF-4574-981C-BB15583E3312 @default.
- Q59216981 P356 1758-2652-11-S1-P308 @default.
- Q59216981 P1433 Q6296158 @default.
- Q59216981 P1476 "96 weeks pharmacoeconomic outcome of lopinavir/r monotherapy as maintenance strategy in HIV+ patients with suppressed viral load. OK04-PharmECO analysis" @default.
- Q59216981 P2093 "A Burgos" @default.
- Q59216981 P2093 "E Cabrero" @default.
- Q59216981 P2093 "F Pulido" @default.
- Q59216981 P2093 "I Méndez" @default.
- Q59216981 P2093 "JR Arribas" @default.
- Q59216981 P2093 "M Norton" @default.
- Q59216981 P2093 "P Lázaro" @default.
- Q59216981 P2888 1758-2652-11-s1-p308 @default.
- Q59216981 P304 "P308" @default.
- Q59216981 P31 Q13442814 @default.
- Q59216981 P356 "10.1186/1758-2652-11-S1-P308" @default.
- Q59216981 P433 "Suppl 1" @default.
- Q59216981 P478 "11" @default.
- Q59216981 P577 "2008-01-01T00:00:00Z" @default.
- Q59216981 P6179 "1022568612" @default.
- Q59216981 P921 Q18123741 @default.
- Q59216981 P921 Q2528140 @default.
- Q59216981 P921 Q422585 @default.